Soleno Therapeutics (SLNO) Other Working Capital Changes (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Other Working Capital Changes of -$133000.0 for Q1 2026, down 232.5% year-over-year from $100377.4 in Q1 2025, and down 232.5% quarter-over-quarter from -$40000.0 in Q1 2025.
Soleno Therapeutics (SLNO) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Other Working Capital Changes for 6 consecutive years, with -$133000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 232.5% year-over-year to -$133000.0; the TTM figure through Mar 2026 stood at -$354000.0 (down 59.46% YoY), while the FY2025 annual figure was -$308000.0, down 68.31% from the prior year.
- Other Working Capital Changes slipped to -$133000.0 in Q1 2026 per SLNO's latest filing, from -$40000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.9 million in Q4 2025 and bottomed at -$3.5 million in Q2 2025.
- Historically, Other Working Capital Changes has averaged $319529.4 across 5 years, with a median of -$26000.0 in 2024.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes surged 93.75% — and 2025, when it sank 3900.0%.
- Soleno Therapeutics' Other Working Capital Changes stood at -$308000.0 in 2023, then soared by 41.56% to -$180000.0 in 2024, then jumped by 77.78% to -$40000.0 in 2025, then tumbled by 232.5% to -$133000.0 in 2026.
- Business Quant data shows SLNO's Other Working Capital Changes at -$133000.0 in Q1 2026, -$40000.0 in Q1 2025, and -$180000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -780,000.00 |
| Mar 31, 2026 | -780,000.00 |
| Mar 31, 2026 | -780,000.00 |
| Dec 31, 2025 | 4.93 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Sep 30, 2025 | -115,000.00 |
| Sep 30, 2025 | -115,000.00 |
| Sep 30, 2025 | -115,000.00 |
| Jun 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | -172,000.00 |
| Sep 30, 2024 | -172,000.00 |